Published in Gene Therapy Weekly, October 5th, 1998
Most cancer gene therapy approaches are based on destruction of cancer cells rather than the prevention of tumor formation. H. Li and H. Lu and a team of colleagues from several institutions angled their gene therapy research towards the delivery of an angiogenesis inhibitor via an adenoviral vector ("Adenovirus-Mediated Delivery of a uPA/uPAR antagonist suppresses Angiogenesis-Dependent Tumor Growth and Dissemination in Mice," Gene Therapy, August 1998;5(8):1105-13).
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.